Chris Lewis
Stock Analyst at Roth Capital
(3.03)
# 1,262
Out of 5,149 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $7.82 | -48.85% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $104.29 | -84.66% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $29.83 | -51.39% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $103.37 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.43 | +1,298.60% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $7.82
Upside: -48.85%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $104.29
Upside: -84.66%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $29.83
Upside: -51.39%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $103.37
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.43
Upside: +1,298.60%